Nigeria spends US$1.5M as it grapples with rising Multi-Drug Resistant TB
Nigeria, with the world’s third highest TB burden, sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multi-drug resistant
Publication Date:
13/04/2015